Acorn Regulatory
Acorn Regulatory is an ISO-certified medical device and pharmaceutical consulting firm that specializes in assisting companies with European regulatory approvals and quality assurance.
| |
Acorn Regulatory | |
---|---|
Industry | Pharmaceutical
Medical Devices Pharmacovigilance |
Founded | 2002 |
Headquarters | Suite 6 Powerstown House
Gurtnafleur Business Park, Clonmel, Co. Tipperary, Ireland |
History
1. Since 2002, Acorn Regulatory has been synonymous with success in its field. In almost 15 years, they take pride in never receiving a rejection from a Competent Authority. That’s a 100% success rate! Client testimonials are readily available on our corporate website.
Acorn Regulatory is an ISO-certified medical device and pharmaceutical consulting firm that specializes in assisting companies with European regulatory approvals and quality assurance. Our practice areas include:
- 2.Pharmaceutical (including regulatory affairs)
- 3.Medical Devices (including regulatory affairs)
- 4.Pharmacovigilance
- Clinical Trials Services
- WDA Services
- EU Authorised Representative
- Known as eCTD experts.
- PV Auditing
Services include:
Acting as the EU Authorised Representative Wholesale Distribution Authorisations Advertising Compliance Review of medicinal products Resourcing and Outsourcing of Regulatory Affairs Specialists Acorn Regulatory is headquartered in Tipperary, Ireland. Their team is one of the most experienced and highly regarded regulatory affairs teams in Europe. They have, over the course of their careers, worked on myriad projects for healthcare companies of all sizes. The team continues to grow at their offices in Ireland and with their staff on client sites throughout the world. The company has 100% compliance with the reporting timelines in relation to the reporting of adverse reactions as individual case safety reports (ICSR) (https://acornregulatory.com/what-we-do/pharmacovigilance/). Routine literature reviews, PV auditing, electronic reporting, and pharmacovigilance training are services offered by their pharmacovigilance division.
Controversies
Top 5 Recent Tweets
Date | Author | Comment |
---|---|---|
April 09, 2021 | Jyotsna2 | @acorn Yes! And privatisation is not without its faults. Then solve the issues as they arise? Organise regulatory b… https://t.co/qBNYu8ZnqX |
April 08, 2021 | Acorn_Reg | This extended edition of Regulatory Intelligence looks at our best writing from a wide range of sectors including:… https://t.co/gCnzFBgdyb |
April 03, 2021 | Acorn_Reg | In our updated whitepaper we look at issues that companies need to consider as regulations and guidelines become br… https://t.co/YuXU1aTcaM |
April 03, 2021 | Acorn_Reg | The issue of wholesale distribution authorisations remains a hot topic in regulatory and quality circles. Download… https://t.co/Lane0VYYnq |